Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health

Mar.12
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health

Partner Content

Content provided by 【GFN】

 

Registration is now open for the 13th annual Global Forum on Nicotine (GFN26), taking place from Wednesday 3 to Friday 5 June at The Warsaw Presidential Hotel in Warsaw, Poland. Themed Prohibition and public health, this year’s event will examine a deep structural contradiction emerging between science and global public health policy.

 

Despite causing millions of deaths each year, combustible cigarettes remain universally and legally available. Meanwhile, far lower-risk nicotine products – nicotine vapes, pouches, heated tobacco products or Swedish-style snus – are facing blanket or partial bans in many countries. Nicotine does not cause the cancers, cardiovascular disease and respiratory illnesses associated with smoking; these are driven by the toxic byproducts of combustion. Alternative products deliver nicotine without burning tobacco, significantly reducing exposure.

 

 

Regulation, not prohibition

 

 

Effective regulatory frameworks balance the concern over prevention of youth uptake with the huge opportunities to reduce the global burden of death and disease caused by a billion adults who smoke. Yet prohibitive or restrictive policies are endorsed by influential global institutions such as the World Health Organization, justified as being for the ‘protection’ of public health.

 

This directly contradicts years of large-scale epidemiological evidence demonstrating that safer nicotine products reduce smoking rates. In countries where safer products are accessible and affordable, such as Sweden, Norway, the United Kingdom, New Zealand and Japan, cigarette sales have declined much more rapidly, as millions switch away from smoking to safer options.

 

Even as the science-base in support of tobacco harm reduction’s role in public health strengthens, it seems the opposition to safer nicotine products intensifies. GFN26 will critically examine the ways in which prohibition is jeopardising public health goals by entrenching cigarette use, fuelling illicit tobacco and nicotine markets and undermining global efforts to reduce smoking-related disease.

 

The programme will feature keynote addresses, panel discussions and interactive workshops, alongside the return of GFN’s popular Science Lab. Panels and keynote will address:

  • The health, wellbeing and ethical implications of prohibition;
  • The economic impact of prohibition;
  • The unintended consequences of prohibition on illicit markets and organised crime.

 

Jessica Harding, Conference Director, GFN26, said:

 

“Prohibition is increasing at a time when innovation offers unprecedented opportunities to accelerate the end of smoking. Nicotine consumers are paying the price. Unable to access regulated products, millions are forced to choose: either risk using unregulated or illicit nicotine products, or return to deadly tobacco. When cigarettes remain on sale everywhere and safer alternatives are banned or heavily restricted, who is really being protected?”

 

 

An inclusive global platform

 

 

Established in 2014, the Global Forum on Nicotine is the only international conference dedicated to the role of safer nicotine products in helping people move away from smoking.

 

Its open-door, multi-stakeholder approach is unique, welcoming consumers who have switched from smoking, public health professionals, researchers, policymakers, regulators, parliamentarians, manufacturers and media representatives. Many of these groups are either excluded or siloed in other international forums.

 

Speakers and delegates will debate how best to promote evidence-based policy in an environment where harm reduction is frequently portrayed as industry-driven or inherently suspect. By fostering dialogue across sectors, GFN aims to advance practical solutions to reduce smoking-related harm.

 

Affordably priced, GFN26 is a hybrid event. Accommodation at The Warsaw Presidential can be booked at a discounted rate until Monday 4 May. Selected sessions will be streamed live free of charge and simultaneously translated into Spanish and Russian, widening access, and the conference’s broadcast arm, GFN•TV, will again provide live commentary.

 

Opportunities for community participation include the GFN Fives – short, five-minute video contributions published online – and the return of Science Lab, where researchers present emerging findings to an international audience. GFN is open to everyone with an interest in the future of tobacco and nicotine policy – join the event and make your voice heard.

 

In 2026, 2Firsts will continue to serve as an official media partner of GFN, delivering the latest coverage to readers worldwide.

 

GFN 2025
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
Indonesia’s BNN Pushes Total Vape Ban as Health Ministry Tightens Tobacco Packaging Rules, Putting $40 Billion Industry at Risk
Indonesia’s BNN Pushes Total Vape Ban as Health Ministry Tightens Tobacco Packaging Rules, Putting $40 Billion Industry at Risk
Indonesia is entering a new phase of debate over vape and tobacco regulation. The National Narcotics Agency (BNN) has proposed a total vape ban, with some lawmakers supporting stronger restrictions. At the same time, the Health Ministry is advancing tobacco and nicotine regulations under Government Regulation No. 28/2024, including measures such as plain packaging and product controls. Tobacco and vape industries have warned that tighter rules could affect a sector worth around $40 billion, supporting about 6 million jobs and contributing significant tax revenue.
Jul.27
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Spain Plans to Extend Smoking Ban to Terraces and Beaches, Bringing Vapes Under New Restrictions
Spain Plans to Extend Smoking Ban to Terraces and Beaches, Bringing Vapes Under New Restrictions
Spain is advancing a new tobacco-control reform that would expand smoking restrictions to additional public spaces, including restaurant terraces and beaches, while bringing vaping and other nicotine products into the same regulatory framework. The proposed measures aim to reduce secondhand smoke exposure, protect young people and expand smoke-free environments. The proposal remains under legislative development, and final implementation details have not yet been confirmed.
Jul.23
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
China’s Jinhua Tobacco Launches CNY 2.7 Million Procurement for E-Cigarette Violation Lead Monitoring Services
Jinhua Tobacco, a municipal tobacco company in China’s Zhejiang province, has launched a public tender for e-cigarette-related violation lead monitoring and consulting services. The project is valued at CNY 2.7 million and covers data resource integration and analytical consulting services for 36 months from contract signing. The procurement reflects the use of external data and analysis services to support local tobacco companies’ market oversight activities related to e-cigarettes.
Aug.07